Ana Maria Segura, MD, MPH

Dr. Segura graduated from Universidad Javeriana Medical School, Bogota, Colombia. She completed post-graduate training in Surgical Pathology at the same institution and fellowships in Cytopathology (Harvard Medical School), Gastrointestinal Pathology (Baylor College of Medicine), Cardiovascular Pathology (THI) and a Master’s degree in Public Health (Tulane University). She is an Associate Research Investigator at THI and a Clinical Assistant Professor at Baylor College of Medicine.

Show full bio

Her main areas of interest are heart failure, ventricular remodeling, transplantation, ventricular assist devices, aortic pathology and electrophysiology. Her work has been published in several peer-reviewed journals and has been presented in multiple national and international conferences.

See Publications

Texas Heart Institute Positions

Interests

  • Heart failure
  • Electrophysiology
  • Ventricular remodeling

Education

  • Undergraduate:

    Universidad Javeriana Medical School, Bogota, Colombia

  • Postgraduate:

    Universidad Javeriana Medical School, Bogota, Colombia

  • Fellowships:

    Harvard Medical School

Honors, Awards and Memberships

Publications

4862227 558WQRIW 1 alternatives-to-animal-experimentation 10 date desc Segura 4862 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WZU674H4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLi%2C%20K.%2C%20%26lt%3Bstrong%26gt%3BSegura%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20M.%2C%20Sun%2C%20J.%20et%20al.%20%282022%29.%20Rare%20delayed%20cardiac%20tamponade%20in%20a%20pig%20after%20cardiac%20surgery.%20%26lt%3Bi%26gt%3BVet%20Med%20Sci%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fvms3.892%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fvms3.892%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rare%20delayed%20cardiac%20tamponade%20in%20a%20pig%20after%20cardiac%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ke%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Maria%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junping%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emerson%20C.%22%2C%22lastName%22%3A%22Perin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdelmotagaly%22%2C%22lastName%22%3A%22Elgalad%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Delayed%20cardiac%20tamponade%2C%20a%20life-threatening%20complication%20of%20pericardial%20effusion%20in%20humans%2C%20has%20rarely%20been%20described%20in%20large%20animal%20models.%20We%20report%20here%20a%20pig%20with%20cardiac%20tamponade%20that%20developed%2029%20days%20after%20cardiac%20surgery.%5CnSTUDY%20DESIGN%3A%20Case%20report.%5CnANIMALS%3A%20One%2045-kg%20domestic%20pig.%5CnMETHODS%3A%20Open-chest%20surgery%20was%20performed%20on%20a%20pig%20to%20induce%20chronic%20heart%20failure.%20At%2015%20days%20after%20surgery%2C%20the%20pig%26%23039%3Bs%20breathing%20appeared%20laboured%3B%20induced%20heart%20failure%20was%20considered%20the%20cause.%20Routine%20heart%20failure%20medications%20were%20administered.%5CnRESULTS%3A%20On%20day%2028%2C%20the%20pig%26%23039%3Bs%20status%20deteriorated.%20On%20day%2029%2C%20echocardiography%20performed%20just%20before%20the%20pig%26%23039%3Bs%20death%20showed%20a%20large%20pericardial%20effusion%2C%20mainly%20in%20the%20lateral%20and%20anterior%20walls%20of%20the%20right%20heart%2C%20with%20several%20fibre%20exudation%20bands.%20The%20right%20heart%20was%20severely%20compressed%20with%20an%20extremely%20small%20right%20ventricle.%20An%20emergency%20sternotomy%20was%20unsuccessful.%20Pathologic%20examination%20showed%20a%20severely%20thickened%2C%20fibrous%20pericardium.%20The%20pericardial%20sac%20was%20distended%20%28up%20to%204.5%5Cu00a0cm%29%20and%20was%20full%20of%20dark%20brown%2C%20soft%2C%20friable%20material.%20Epicardial%20haemorrhage%20with%20a%20fresh%2C%20organised%20thrombus%20was%20noted%20in%20the%20pericardium.%5CnCONCLUSION%3A%20Delayed%20tamponade%20occurring%20at%20least%2015%20days%20after%20open-chest%20surgery%20is%20easy%20to%20misdiagnose%20or%20overlook%20in%20large%20animal%20models%20where%20attention%20is%20often%20focused%20on%20primary%20pathological%20model%20changes.%20To%20decrease%20mortality%20in%20animal%20models%2C%20researchers%20should%20be%20aware%20of%20potential%20complications%20and%20use%20the%20same%20level%20of%20follow-up%20monitoring%20of%20large%20animals%20as%20in%20clinical%20care.%22%2C%22date%22%3A%22Aug%2003%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fvms3.892%22%2C%22ISSN%22%3A%222053-1095%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%228EPJLFD3%22%2C%228HHBIBI6%22%2C%2242FKW3I4%22%2C%22RB23UBKZ%22%2C%22558WQRIW%22%2C%22CA7YD8T8%22%2C%226CLB47ZH%22%2C%228PULYTSK%22%2C%22VTWWYEIB%22%5D%2C%22dateModified%22%3A%222022-09-02T20%3A14%3A08Z%22%7D%7D%2C%7B%22key%22%3A%223WNB4RQY%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Buja%20and%20Segura%22%2C%22parsedDate%22%3A%222021-11-23%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBuja%2C%20L.%20M.%20and%20%26lt%3Bstrong%26gt%3BSegura%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20M.%20%282021%29.%20Victor%20J.%20Ferrans%2C%20MD%2C%20PhD%20%281937-2001%29.%20%26lt%3Bi%26gt%3BCardiology%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000521084%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000521084%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Victor%20J.%20Ferrans%2C%20MD%2C%20PhD%20%281937-2001%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Maria%22%2C%22lastName%22%3A%22Segura%22%7D%5D%2C%22abstractNote%22%3A%22NA.%22%2C%22date%22%3A%222021-11-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000521084%22%2C%22ISSN%22%3A%221421-9751%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22558WQRIW%22%2C%22IEPEFS59%22%5D%2C%22dateModified%22%3A%222022-02-04T20%3A14%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22MVS8UW7J%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Palaskas%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPalaskas%2C%20N.%20L.%2C%20%26lt%3Bstrong%26gt%3BSegura%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%2C%20Lelenwa%2C%20L.%20et%20al.%20%282021%29.%20Immune%20checkpoint%20inhibitor%20myocarditis%3A%20elucidating%20the%20spectrum%20of%20disease%20through%20endomyocardial%20biopsy.%20%26lt%3Bi%26gt%3BEur%20J%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fejhf.2265%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fejhf.2265%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immune%20checkpoint%20inhibitor%20myocarditis%3A%20elucidating%20the%20spectrum%20of%20disease%20through%20endomyocardial%20biopsy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%20L.%22%2C%22lastName%22%3A%22Palaskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Lelenwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bilal%20A.%22%2C%22lastName%22%3A%22Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumit%20K.%22%2C%22lastName%22%3A%22Subudhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Lopez-Mattei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20B.%22%2C%22lastName%22%3A%22Durand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Deswal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bihong%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Maximilian%20Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cezar%22%2C%22lastName%22%3A%22Iliescu%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20Although%20immune%20checkpoint%20inhibitor%20%28ICI%29%20myocarditis%20carries%20a%20high%20reported%20mortality%2C%20increasing%20reports%20of%20smoldering%20myocarditis%20suggest%20a%20clinical%20spectrum%20of%20disease.%20Endomyocardial%20biopsy%20%28EMB%29%20remains%20the%20gold%20standard%20for%20diagnosis%20of%20ICI%20myocarditis%2C%20but%20different%20pathologic%20diagnostic%20criteria%20exist.%20The%20objective%20of%20this%20study%20was%20to%20classify%20the%20spectrum%20of%20ICI%20myocarditis%20and%20myocardial%20inflammation%20by%20pathology%20findings%20on%20EMB%20and%20correlate%20this%20with%20clinical%20outcomes.%5CnMETHODS%20AND%20RESULTS%3A%20All%20patients%20who%20had%20EMB%20at%20MD%20Anderson%20Cancer%20Center%20between%20January%202018%20and%20August%202019%20for%20suspected%20ICI%20myocarditis%20were%20retrospectively%20reviewed.%20A%20grading%20system%20%28Grades%200-2%29%20based%20on%20the%20degree%20of%20inflammatory%20infiltrate%20was%20developed%20by%20pathologists.%20Cardiovascular%20outcomes%20and%20treatment%20were%20compared%20between%20grades%20of%20pathology.%20We%20identified%2028%20patients%20who%20had%20EMB%20for%20suspected%20ICI%20myocarditis%2C%20of%20which%2018%20were%20positive%20for%20myocarditis%5C%2Finflammation.%20There%20were%20four%20deaths%20%28two%20in%20Grade%202%20and%20two%20in%20Grade%201%29%2C%20but%20only%20one%20was%20attributable%20to%20myocarditis.%20Grade%202%20patients%20had%20no%20myocarditis-associated%20deaths%20despite%20having%20the%20highest%20troponin%20T%20values%20%28median%202063%5Cu2009pg%5C%2FmL%29.%20Four%20patients%20with%20Grade%201%20myocardial%20inflammation%20continued%20ICI%20without%20any%20immunomodulation%2C%20and%20all%20were%20alive%20without%20adverse%20cardiovascular%20events%20at%20follow-up.%5CnCONCLUSION%3A%20We%20defined%20an%20EMB%20grading%20system%20for%20ICI%20myocarditis%20encompassing%20a%20spectrum%20of%20histologic%20findings%20of%20inflammatory%20infiltrates.%20A%20subset%20of%20low-grade%20myocardial%20inflammation%20patients%20were%20able%20to%20continue%20ICI%20without%20immunosuppressive%20therapy.%20Further%20studies%20are%20needed%20to%20identify%20low-risk%20patients%20who%20can%20be%20safely%20treated%20with%20ICI.%22%2C%22date%22%3A%22Jun%2011%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fejhf.2265%22%2C%22ISSN%22%3A%221879-0844%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222021-10-29T18%3A06%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22VGVJDE3A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yan%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYan%2C%20J.%20S.%2C%20Orecchioni%2C%20M.%2C%20Vitale%2C%20F.%20et%20al.%20%282021%29.%20Biocompatibility%20studies%20of%20macroscopic%20fibers%20made%20from%20carbon%20nanotubes%3A%20Implications%20for%20carbon%20nanotube%20macrostructures%20in%20biomedical%20applications.%20%26lt%3Bi%26gt%3BCarbon%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B173%26lt%3B%5C%2Fi%26gt%3B%2C%20462%26%23x2013%3B476.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carbon.2020.10.077%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carbon.2020.10.077%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biocompatibility%20studies%20of%20macroscopic%20fibers%20made%20from%20carbon%20nanotubes%3A%20Implications%20for%20carbon%20nanotube%20macrostructures%20in%20biomedical%20applications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Stephen%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Orecchioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Flavia%22%2C%22lastName%22%3A%22Vitale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%20A.%22%2C%22lastName%22%3A%22Coco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Duret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Antonucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushma%20Sri%22%2C%22lastName%22%3A%22Pamulapati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20W.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%20S.%22%2C%22lastName%22%3A%22Dewey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moises%22%2C%22lastName%22%3A%22Di%20Sante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Maria%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cansu%22%2C%22lastName%22%3A%22Gurcan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Di%20Lisa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Acelya%22%2C%22lastName%22%3A%22Yilmazer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20D.%22%2C%22lastName%22%3A%22McCauley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20T.%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klaus%22%2C%22lastName%22%3A%22Ley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucia%20G.%22%2C%22lastName%22%3A%22Delogu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Pasquali%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.carbon.2020.10.077%22%2C%22ISSN%22%3A%2200086223%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0008622320310502%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222020-12-03T20%3A25%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22HFBEXFTU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Corporan%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCorporan%2C%20D.%2C%20%26lt%3Bstrong%26gt%3BSegura%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20and%20Padala%2C%20M.%20%282021%29.%20Ultrastructural%20adaptation%20of%20the%20cardiomyocyte%20to%20chronic%20mitral%20regurgitation.%20%26lt%3Bi%26gt%3BFront%20Cardiovasc%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%20714774.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2021.714774%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2021.714774%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ultrastructural%20adaptation%20of%20the%20cardiomyocyte%20to%20chronic%20mitral%20regurgitation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniella%22%2C%22lastName%22%3A%22Corporan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muralidhar%22%2C%22lastName%22%3A%22Padala%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Mitral%20regurgitation%20%28MR%29%20imposes%20volume%20overload%20on%20the%20left%20ventricle%20%28LV%29%20and%20elevates%20wall%20stress%2C%20triggering%20its%20adverse%20remodeling.%20Pronounced%20LV%20dilation%2C%20minimal%20wall%20thinning%2C%20and%20a%20gradual%20decline%20in%20cardiac%20ejection%20fraction%20%28EF%29%20are%20observed.%20The%20structural%20changes%20in%20the%20myocardium%20that%20define%20these%20gross%2C%20organ%20level%20remodeling%20are%20not%20known.%20Cardiomyocyte%20elongation%20and%20slippage%20have%20both%20been%20hypothesized%2C%20but%20neither%20are%20confirmed%2C%20nor%20are%20the%20changes%20to%20the%20cardiomyocyte%20structure%20known.%20Using%20a%20rodent%20model%20of%20MR%2C%20we%20used%20immunohistochemistry%20and%20transmission%20electron%20microscopy%20%28TEM%29%20to%20describe%20the%20ultrastructural%20remodeling%20of%20the%20cardiomyocyte.%20Methods%3A%20Twenty-four%20male%20Sprague-Dawley%20rats%20%28350-400%20g%29%20were%20assigned%20to%20two%20groups%3A%20group%20%281%29%20rats%20induced%20with%20severe%20MR%20%28n%20%3D%2018%29%20and%20group%20%282%29%20control%20rats%20that%20were%20healthy%20and%20age%20and%20weight%20matched%20%28n%20%3D%206%29.%20MR%20was%20induced%20in%20the%20beating%20heart%20using%20a%2023-G%20ultrasound-guided%2C%20transapical%20needle%20to%20perforate%20the%20anterior%20mitral%20leaflet%2C%20and%20the%20rats%20were%20followed%20to%202%2C%2010%2C%20and%2020%20weeks%20%28n%20%3D%206%5C%2Ftime-point%29.%20Echocardiography%20was%20performed%20to%20quantify%20MR%20severity%20and%20to%20measure%20LV%20volume%20and%20function%20at%20each%20time-point.%20Explanted%20myocardial%20tissue%20were%20examined%20with%20TEM%20and%20immunohistochemistry%20to%20investigate%20the%20ultrastructural%20changes.%20Results%3A%20MR%20induced%20rapid%20and%20significant%20increase%20in%20end-diastolic%20volume%20%28EDV%29%2C%20with%20a%2050%25%20increase%20by%202%20weeks%2C%20compared%20with%20control.%20Rise%20in%20end-systolic%20volume%20%28ESV%29%20was%20more%20gradual%3B%20however%2C%20by%2020%20weeks%2C%20both%20EDV%20and%20ESV%20in%20MR%20rats%20were%20increased%20by%20126%25%20compared%20with%20control.%20A%20significant%20decline%20in%20EF%20was%20measured%20at%2010%20weeks%20of%20MR.%20At%20the%20ultrastructural%20level%2C%20as%20early%20as%202%20weeks%20after%20MR%2C%20cardiomyocyte%20elongation%20and%20increase%20in%20cross-sectional%20area%20were%20observed.%20TEM%20depicted%20sarcomere%20shortening%2C%20with%20loss%20of%20Z-line%20and%20I-band.%20Desmin%2C%20a%20cytoskeletal%20protein%20that%20is%20uniformly%20distributed%20along%20the%20length%20of%20the%20cardiomyocyte%2C%20was%20disorganized%20and%20localized%20to%20the%20intercalated%20disc%2C%20in%20the%20rats%20induced%20with%20MR%20and%20not%20in%20the%20controls.%20In%20the%20rats%20with%20MR%2C%20the%20linear%20registry%20of%20the%20mitochondrial%20arrangement%20along%20the%20sarcomeres%20was%20lost%2C%20with%20mitochondrial%20fragmentation%2C%20aggregation%20around%20the%20nucleus%2C%20and%20irregularities%20in%20the%20cristae.%20Discussion%3A%20In%20the%20setting%20of%20chronic%20mitral%20regurgitation%2C%20LV%20dilatation%20occured%20by%20cardiomyocyte%20elongation%2C%20which%20manifests%20at%20the%20subcellular%20level%20as%20distinct%20ultrastructural%20alterations%20of%20the%20sarcomere%2C%20cytoskeleton%2C%20and%20mitochondria.%20Since%20the%20cytoskeleton%20not%20only%20provides%20tensegrity%20but%20has%20functional%20consequences%20on%20myocyte%20function%2C%20further%20investigation%20into%20the%20impact%20of%20cytoskeletal%20remodeling%20on%20progressive%20heart%20failure%20or%20recovery%20of%20function%20upon%20correcting%20the%20valve%20lesion%20are%20needed.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffcvm.2021.714774%22%2C%22ISSN%22%3A%222297-055X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22558WQRIW%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A28%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22FQ4CDIWA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Monroe%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMonroe%2C%20M.%20N.%2C%20Zhaorigetu%2C%20S.%2C%20Gupta%2C%20V.%20S.%20et%20al.%20%282020%29.%20Extracellular%20vesicles%20influence%20the%20pulmonary%20arterial%20extracellular%20matrix%20in%20congenital%20diaphragmatic%20hernia.%20%26lt%3Bi%26gt%3BPediatr%20Pulmonol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fppul.24914%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fppul.24914%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracellular%20vesicles%20influence%20the%20pulmonary%20arterial%20extracellular%20matrix%20in%20congenital%20diaphragmatic%20hernia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeline%20N.%22%2C%22lastName%22%3A%22Monroe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siqin%22%2C%22lastName%22%3A%22Zhaorigetu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikas%20S.%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Di%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katelyn%20D.%22%2C%22lastName%22%3A%22Givan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20L.%22%2C%22lastName%22%3A%22Curylo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20D.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20S.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20Jane%22%2C%22lastName%22%3A%22Grande-Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20T.%22%2C%22lastName%22%3A%22Harting%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Abnormal%20pulmonary%20vasculature%20directly%20affects%20the%20development%20and%20progression%20of%20congenital%20diaphragmatic%20hernia%20%28CDH%29-associated%20pulmonary%20hypertension%20%28PH%29.%20Though%20overarching%20structural%20and%20cellular%20changes%20in%20CDH-affected%20pulmonary%20arteries%20have%20been%20documented%2C%20the%20precise%20role%20of%20the%20extracellular%20matrix%20%28ECM%29%20in%20the%20pulmonary%20artery%20%28PA%29%20pathophysiology%20remains%20undefined.%20Here%2C%20we%20quantify%20the%20structural%2C%20compositional%2C%20and%20mechanical%20CDH-induced%20changes%20in%20the%20main%20and%20distal%20PA%20ECM%20and%20investigate%20the%20efficacy%20of%20mesenchymal%20stem%20cell-derived%20extracellular%20vesicles%20%28MSC-EVs%29%20as%20a%20therapy%20to%20ameliorate%20pathological%20vascular%20ECM%20changes.%5CnMETHODS%3A%20Pregnant%20Sprague-Dawley%20rodents%20were%20administered%20nitrofen%20to%20induce%20CDH-affected%20pulmonary%20vasculature%20in%20the%20offspring.%20A%20portion%20of%20CDH-affected%20pups%20was%20treated%20with%20intravenous%20infusion%20of%20MSC-EVs%20%281%5Cu2009%5Cu00d7%5Cu20091010%20%5C%2FmL%29%20upon%20birth.%20A%20suite%20of%20histological%2C%20mechanical%2C%20and%20transmission%20electron%20microscopic%20analyses%20were%20utilized%20to%20characterize%20the%20PA%20ECM.%5CnRESULTS%3A%20The%20CDH%20model%20main%20PA%20presented%20significantly%20altered%20characteristics-including%20greater%20vessel%20thickness%2C%20greater%20lysyl%20oxidase%20%28LOX%29%20expression%2C%20and%20a%20relatively%20lower%20ultimate%20tensile%20strength%20of%2013.6%5Cu2009MPa%20compared%20to%20control%20tissue%20%2825.1%5Cu2009MPa%29%2C%20suggesting%20that%20CDH%20incurs%20ECM%20structural%20disorganization.%20MSC-EV%20treatment%20demonstrated%20the%20potential%20to%20reverse%20CDH-related%20changes%2C%20particularly%20through%20rapid%20inhibition%20of%20ECM%20remodeling%20enzymes%20%28LOX%20and%20MMP-9%29.%20Additionally%2C%20MSC-EV%20treatment%20bolstered%20structural%20aspects%20of%20the%20PA%20ECM%20and%20mitigated%20pathological%20disorganization%20as%20exhibited%20by%20increased%20medial%20wall%20thickness%20and%20stiffness%20that%2C%20while%20not%20significantly%20altered%2C%20trends%20away%20from%20CDH-affected%20tissue.%5CnCONCLUSIONS%3A%20These%20data%20demonstrate%20notable%20ECM%20remodeling%20in%20the%20CDH%20pulmonary%20vasculature%2C%20along%20with%20the%20capacity%20of%20MSC-EVs%20to%20attenuate%20pathological%20ECM%20remodeling%2C%20identifying%20MSC-EVs%20as%20a%20potentially%20efficacious%20therapeutic%20for%20CDH-associated%20pulmonary%20hypertension.%22%2C%22date%22%3A%22Jun%2022%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fppul.24914%22%2C%22ISSN%22%3A%221099-0496%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222020-08-12T18%3A28%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22Z6T4B7YD%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jeyakumar%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJeyakumar%2C%20N.%2C%20Etchegaray%2C%20M.%2C%20Henry%2C%20J.%20et%20al.%20%282020%29.%20The%20terrible%20triad%20of%20checkpoint%20inhibition%3A%20A%20case%20report%20of%20myasthenia%20gravis%2C%20myocarditis%2C%20and%20myositis%20induced%20by%20cemiplimab%20in%20a%20patient%20with%20metastatic%20cutaneous%20squamous%20cell%20carcinoma.%20%26lt%3Bi%26gt%3BCase%20Reports%20Immunol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2020%26lt%3B%5C%2Fi%26gt%3B%2C%205126717.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2020%5C%2F5126717%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2020%5C%2F5126717%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20terrible%20triad%20of%20checkpoint%20inhibition%3A%20A%20case%20report%20of%20myasthenia%20gravis%2C%20myocarditis%2C%20and%20myositis%20induced%20by%20cemiplimab%20in%20a%20patient%20with%20metastatic%20cutaneous%20squamous%20cell%20carcinoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikeshan%22%2C%22lastName%22%3A%22Jeyakumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikel%22%2C%22lastName%22%3A%22Etchegaray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Lelenwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bihong%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20We%20report%20a%20case%20of%20a%20patient%20with%20squamous%20cell%20carcinoma%20%28SCC%29%20who%20developed%20myasthenia%20gravis%20%28MG%29%2C%20myositis%2C%20and%20myocarditis%20after%20receiving%20cemiplimab%2C%20an%20anti-PD-1%20immune%20checkpoint%20inhibitor%20%28ICI%29.%20Case%20Presentation.%20An%2086-year-old%20man%20with%20metastatic%20periocular%20SCC%20presented%20with%20decreased%20vision%20in%20the%20left%20eye%2C%20severe%20fatigue%2C%20and%20lower%20back%20and%20bilateral%20hip%20pain%203%20weeks%20after%20receiving%20cemiplimab.%20Within%20hours%2C%20he%20developed%20dysphonia%2C%20pharyngeal%20secretions%2C%20and%20dysphagia%2C%20necessitating%20intubation.%20Endomyocardial%20biopsy%20revealed%20active%20lymphocyte-mediated%20necrosis%20consistent%20with%20ICI-induced%20myocarditis.%20Anti-striated%20muscle%20and%20anti-acetylcholine%20receptor%20antibodies%20were%20elevated%2C%20consistent%20with%20myositis%20and%20myasthenia%20gravis.%20Despite%20plasma%20exchange%20therapy%2C%20steroids%2C%20and%20intravenous%20immunoglobulin%2C%20he%20died%20from%20cardiac%20arrest.%5CnConclusions%3A%20The%20presence%20of%20myasthenia%20gravis%2C%20myocarditis%2C%20or%20myositis%20should%20prompt%20evaluation%20for%20all%20three%20toxicities%20as%20they%20may%20represent%20an%20overlap%20syndrome.%20The%20severity%20of%20these%20immunotoxicities%20highlights%20the%20need%20for%20clinicians%20to%20suspect%20multiple%20simultaneous%20adverse%20effects%20of%20ICIs.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1155%5C%2F2020%5C%2F5126717%22%2C%22ISSN%22%3A%222090-6609%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222020-08-12T18%3A51%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22YV4BNIL3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20Y.%2C%20Beketaev%2C%20I.%2C%20%26lt%3Bstrong%26gt%3BSegura%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20M.%20et%20al.%20%282020%29.%20Contribution%20of%20increased%20expression%20of%20Yin%20Yang%202%20to%20development%20of%20cardiomyopathy.%20%26lt%3Bi%26gt%3BFront%20Mol%20Biosci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%2035.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffmolb.2020.00035%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffmolb.2020.00035%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Contribution%20of%20increased%20expression%20of%20Yin%20Yang%202%20to%20development%20of%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilimbek%22%2C%22lastName%22%3A%22Beketaev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Maria%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yutao%22%2C%22lastName%22%3A%22Xi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiang%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanlin%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22Yin%20Yang%202%20%28YY2%29%20is%20a%20member%20of%20the%20Yin%20Yang%20family%20of%20transcription%20factors.%20Although%20the%20bioactivity%20of%20YY2%20has%20been%20previously%20studied%2C%20its%20role%20in%20cardiovascular%20diseases%20is%20not%20known.%20We%20observed%20the%20increased%20expression%20of%20YY2%20in%20failing%20human%20hearts%20compared%20with%20control%20hearts%2C%20raising%20the%20question%20of%20whether%20YY2%20is%20involved%20in%20the%20pathogenesis%20of%20cardiomyopathy.%20To%20investigate%20the%20potential%20contribution%20of%20YY2%20to%20the%20development%20of%20cardiomyopathy%2C%20we%20crossed%20two%20independent%20transgenic%20%28Tg%29%20mouse%20lines%2C%20pCAG-YY2-Tg%2Band%20alpha-myosin%20heavy%20chain-cre%20%28%5Cu03b1-MHC-Cre%29%2C%20to%20generate%20two%20independent%20double%20transgenic%20%28dTg%29%20mouse%20lines%20in%20which%20the%20conditional%20cardiomyocyte-specific%20expression%20of%20YY2%20driven%20by%20the%20%5Cu03b1-MHC%20promoter%20was%20mediated%20by%20Cre%20recombinase%2C%20starting%20at%20embryonic%20day%209.0.%20In%20dTg%20mice%2C%20we%20observed%20partial%20embryonic%20lethality%20and%20hearts%20with%20defective%20cardiomyocyte%20proliferation.%20Surviving%20dTg%20mice%20from%20both%20lines%20developed%20cardiomyopathy%20and%20heart%20failure%20that%20occurred%20with%20aging%2C%20showing%20different%20degrees%20of%20severity%20that%20were%20associated%20with%20the%20level%20of%20transgene%20expression.%20The%20development%20of%20cardiomyopathy%20was%20accompanied%20by%20increased%20levels%20of%20cardiac%20disease%20markers%2C%20apoptosis%2C%20and%20cardiac%20fibrosis.%20Our%20studies%20further%20revealed%20that%20the%20Cre-mediated%20cardiomyocyte-specific%20increase%20in%20YY2%20expression%20led%20to%20increased%20levels%20of%20Beclin%201%20and%20LC3II%2C%20indicating%20that%20YY2%20is%20involved%20in%20mediating%20autophagic%20activity%20in%20mouse%20hearts%20in%20vivo.%20Also%2C%20compared%20with%20control%20hearts%2C%20dTg%20mouse%20hearts%20showed%20increased%20JNK%20activity.%20Because%20autophagy%20and%20JNK%20activity%20are%20important%20for%20maintaining%20cardiac%20homeostasis%2C%20the%20dysregulation%20of%20these%20signaling%20pathways%20may%20contribute%20to%20YY2-induced%20cardiomyopathy%20and%20heart%20failure%20in%20vivo.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmolb.2020.00035%22%2C%22ISSN%22%3A%222296-889X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K6ZCYSAV%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222020-04-20T19%3A56%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22CFRMY83H%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leach%20et%20al.%22%2C%22parsedDate%22%3A%222017-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLeach%2C%20J.%20P.%2C%20Heallen%2C%20T.%2C%20Zhang%2C%20M.%20et%20al.%20%282017%29.%20Hippo%20pathway%20deficiency%20reverses%20systolic%20heart%20failure%20after%20infarction.%20%26lt%3Bi%26gt%3BNature%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B550%26lt%3B%5C%2Fi%26gt%3B%2C%20260%26%23x2013%3B264.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnature24045%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnature24045%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hippo%20pathway%20deficiency%20reverses%20systolic%20heart%20failure%20after%20infarction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20P.%22%2C%22lastName%22%3A%22Leach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%22%2C%22lastName%22%3A%22Heallen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahdis%22%2C%22lastName%22%3A%22Rahmani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuka%22%2C%22lastName%22%3A%22Morikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20C.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20F.%22%2C%22lastName%22%3A%22Martin%22%7D%5D%2C%22abstractNote%22%3A%22Mammalian%20organs%20vary%20widely%20in%20regenerative%20capacity.%20Poorly%20regenerative%20organs%2C%20such%20as%20the%20heart%20are%20particularly%20vulnerable%20to%20organ%20failure.%20Once%20established%2C%20heart%20failure%20commonly%20results%20in%20mortality.%20The%20Hippo%20pathway%2C%20a%20kinase%20cascade%20that%20prevents%20adult%20cardiomyocyte%20proliferation%20and%20regeneration%2C%20is%20upregulated%20in%20human%20heart%20failure.%20Here%20we%20show%20that%20deletion%20of%20the%20Hippo%20pathway%20component%20Salvador%20%28Salv%29%20in%20mouse%20hearts%20with%20established%20ischaemic%20heart%20failure%20after%20myocardial%20infarction%20induces%20a%20reparative%20genetic%20program%20with%20increased%20scar%20border%20vascularity%2C%20reduced%20fibrosis%2C%20and%20recovery%20of%20pumping%20function%20compared%20with%20controls.%20Using%20translating%20ribosomal%20affinity%20purification%2C%20we%20isolate%20cardiomyocyte-specific%20translating%20messenger%20RNA.%20Hippo-deficient%20cardiomyocytes%20have%20increased%20expression%20of%20proliferative%20genes%20and%20stress%20response%20genes%2C%20such%20as%20the%20mitochondrial%20quality%20control%20gene%2C%20Park2.%20Genetic%20studies%20indicate%20that%20Park2%20is%20essential%20for%20heart%20repair%2C%20suggesting%20a%20requirement%20for%20mitochondrial%20quality%20control%20in%20regenerating%20myocardium.%20Gene%20therapy%20with%20a%20virus%20encoding%20Salv%20short%20hairpin%20RNA%20improves%20heart%20function%20when%20delivered%20at%20the%20time%20of%20infarct%20or%20after%20ischaemic%20heart%20failure%20following%20myocardial%20infarction%20was%20established.%20Our%20findings%20indicate%20that%20the%20failing%20heart%20has%20a%20previously%20unrecognized%20reparative%20capacity%20involving%20more%20than%20cardiomyocyte%20renewal.%22%2C%22date%22%3A%22Oct%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnature24045%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%227IGCL8QC%22%2C%22QH7R47P9%22%2C%22SS2CP8WX%22%2C%22558WQRIW%22%5D%2C%22dateModified%22%3A%222018-05-02T20%3A38%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22MYZPX9MH%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nazeri%20et%20al.%22%2C%22parsedDate%22%3A%222017-06%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNazeri%2C%20A.%2C%20Ganapathy%2C%20A.%20V.%2C%20Massumi%2C%20A.%20et%20al.%20%282017%29.%20Effect%20of%20botulinum%20toxin%20on%20inducibility%20and%20maintenance%20of%20atrial%20fibrillation%20in%20ovine%20myocardial%20tissue.%20%26lt%3Bi%26gt%3BPacing%20Clin%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B40%26lt%3B%5C%2Fi%26gt%3B%2C%20693%26%23x2013%3B702.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.13079%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.13079%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20botulinum%20toxin%20on%20inducibility%20and%20maintenance%20of%20atrial%20fibrillation%20in%20ovine%20myocardial%20tissue%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alireza%22%2C%22lastName%22%3A%22Nazeri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anand%20V.%22%2C%22lastName%22%3A%22Ganapathy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Massumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehran%22%2C%22lastName%22%3A%22Massumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Egemen%22%2C%22lastName%22%3A%22Tuzun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Stainback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana-Maria%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Aberrant%20vagal%20stimulation%20may%20promote%20the%20generation%20and%20propagation%20of%20atrial%20fibrillation%20%28AF%29.%20Researchers%20have%20suggested%20that%20botulinum%20toxin%20%28BTX%29%2C%20a%20neurotoxin%20that%20decreases%20neural%20vagal%20stimulation%2C%20may%20decrease%20the%20incidence%20of%20postoperative%20AF.%20The%20exact%20electrophysiologic%20mechanism%20underlying%20the%20observations%20and%20histopathologic%20alterations%20associated%20with%20BTX%20are%20unclear.%5CnOBJECTIVE%3A%20To%20investigate%20the%20electrophysiologic%2C%20functional%2C%20and%20histopathologic%20effects%20of%20BTX%20on%20fibrillation%20induction%20in%20ovine%20atria.%5CnMETHODS%3A%20Eight%20sheep%20underwent%20BTX%20injections%20into%20their%20pulmonary%20veins%2C%20atrial%20fat%20pads%2C%20and%20ventricular%20walls.%20Electrophysiology%20with%20pacing%20was%20performed%20at%20baseline%20and%207%20days%20after%20injection%20to%20evaluate%20the%20atrial%20effective%20refractory%20period%20%28ERP%29%20and%20vulnerability%20to%20AF%20with%20and%20without%20vagal%20stimulation.%20Echocardiography%20was%20performed%20at%20baseline%20and%20day%207.%20After%20euthanasia%2C%20histopathologic%20analysis%20was%20performed.%5CnRESULTS%3A%20Seven%20sheep%20completed%20the%20study.%20For%20both%20atria%2C%20there%20was%20significant%20shortening%20in%20the%20ERP%20with%20vagal%20stimulation%20versus%20no%20stimulation%20on%20day%200%20but%20not%20on%20day%207.%20More%20aggressive%20pacing%20was%20required%20to%20induce%20AF%20in%20the%20left%20atrium%20on%20day%207%20than%20on%20day%200.%20Echocardiography%20on%20day%207%20showed%20no%20significant%20changes%20in%20ejection%20fraction%20or%20new%20wall-motion%20abnormalities%20of%20the%20left%20and%20right%20ventricle.%20Histopathologic%20analysis%20showed%20no%20significant%20adverse%20effects.%5CnCONCLUSION%3A%20The%20subacute%20BTX%20effect%20reduced%20the%20vulnerability%20of%20atrial%20tissue%20to%20AF%20induction%20and%20reduced%20the%20vagal%20influence%20on%20atrial%20ERP%20shortening%20compared%20to%20baseline%20levels.%20Direct%20BTX%20injection%20did%20not%20cause%20myocardial%20dysfunction%20or%20histologic%20adverse%20effects.%22%2C%22date%22%3A%22Jun%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fpace.13079%22%2C%22ISSN%22%3A%221540-8159%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%22X6Y3USZ6%22%2C%225RXGKSVK%22%2C%22FJXP7WZ4%22%2C%22558WQRIW%22%2C%222NK6UQ4P%22%5D%2C%22dateModified%22%3A%222022-02-17T16%3A56%3A02Z%22%7D%7D%5D%7D
Li, K., Segura, A. M., Sun, J. et al. (2022). Rare delayed cardiac tamponade in a pig after cardiac surgery. Vet Med Sci. https://doi.org/10.1002/vms3.892.
Buja, L. M. and Segura, A. M. (2021). Victor J. Ferrans, MD, PhD (1937-2001). Cardiology. https://doi.org/10.1159/000521084.
Palaskas, N. L., Segura, A., Lelenwa, L. et al. (2021). Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2265.
Yan, J. S., Orecchioni, M., Vitale, F. et al. (2021). Biocompatibility studies of macroscopic fibers made from carbon nanotubes: Implications for carbon nanotube macrostructures in biomedical applications. Carbon 173, 462–476. https://doi.org/10.1016/j.carbon.2020.10.077.
Corporan, D., Segura, A. and Padala, M. (2021). Ultrastructural adaptation of the cardiomyocyte to chronic mitral regurgitation. Front Cardiovasc Med 8, 714774. https://doi.org/10.3389/fcvm.2021.714774.
Monroe, M. N., Zhaorigetu, S., Gupta, V. S. et al. (2020). Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia. Pediatr Pulmonol. https://doi.org/10.1002/ppul.24914.
Jeyakumar, N., Etchegaray, M., Henry, J. et al. (2020). The terrible triad of checkpoint inhibition: A case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma. Case Reports Immunol 2020, 5126717. https://doi.org/10.1155/2020/5126717.
Zhang, Y., Beketaev, I., Segura, A. M. et al. (2020). Contribution of increased expression of Yin Yang 2 to development of cardiomyopathy. Front Mol Biosci 7, 35. https://doi.org/10.3389/fmolb.2020.00035.
Leach, J. P., Heallen, T., Zhang, M. et al. (2017). Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550, 260–264. https://doi.org/10.1038/nature24045.
Nazeri, A., Ganapathy, A. V., Massumi, A. et al. (2017). Effect of botulinum toxin on inducibility and maintenance of atrial fibrillation in ovine myocardial tissue. Pacing Clin Electrophysiol 40, 693–702. https://doi.org/10.1111/pace.13079.